新型S(N)-β-D-葡萄糖苷-4-N-(取代邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑的合成及生物活性

在KOH/acetone体系中,4-N-(取代邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑-3-硫酮(3a～3d)与溴-α-D-四乙酰葡萄糖发生Kenigs-Knorr反应,合成了8个未见报道的S(N)-β-D-乙酰葡萄糖苷,其结构经1H NMR、13C NMR、红外光谱及元素分析等确定.目标化合物的生物活性测试结果表明,它们对金黄色葡萄球菌、白色念珠菌和大肠杆菌均显示了较好的抑菌活性,其效果接近或优于对照药物三氯生和氟康唑的抑菌效能.其中,化合物2-N-(2’,3’,4’,6’-O-四乙酰基-β-D-吡喃葡萄糖基)-4-N-(3,5-二溴邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑-3-硫酮(4d)及3-S-(2’,3’,4’,6’-O-四乙酰基-β-D-吡喃葡萄糖硫基)-4-N-(3,5-二溴邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑(5d)具有较强的抑菌活性.     

1-对甲苯基-5-取代苯基亚胺基-1,2,3-三唑甲酸/甲酰胺的合成及生物活性研究

以对甲基苯胺为原料,经过重氮化反应生成对甲基叠氮苯(1).在强碱性条件下,1分别与氰基乙酸乙酯、氰基乙酰胺反应,制得中间体1-对甲苯基-5-氨基-1,2,3-三唑甲酸乙酯(2)和1-对甲苯基-5-氨基-1,2,3-三唑甲酰胺(5);中间体2经水解生成1-对甲苯基-5-氨基-1,2,3-三唑甲酸(3),进而在弱酸性条件下与取代苯甲醛反应得到6个未见文献报道的目标化合物1-对甲苯基-5-取代苯基亚胺基-1,2,3-三唑甲酸(4a～4f),5与取代苯甲醛反应得到6个未见文献报道的目标化合物1-对甲苯基-5-取代苯基亚胺基-1,2,3-三唑甲酰胺(6a～6f),化合物的结构均经IR,1H NMR,13C NMR确证.初步生物测试表明,12个化合物均表现出良好的抑菌活性,其中化合物4d～4f和6d～6f对金黄色葡萄球菌、白色念球菌的最小抑菌浓度(MIC)值为2～8μg/mL,抗菌效果优于氟康唑和三氯生.     

新型5-甲基-1,2,4-三唑-3-硫酮类化合物的合成及抗菌活性研究

利用生物活性叠加原理,以4-氨基-5-甲基-1,2,4-三唑-3-硫酮为原料,设计合成了15个未见报道的化合物2-N-2′,3′,4′,6′-四-O-乙酰基-β-D-吡喃葡萄糖基-4-N-取代苯基亚胺基-5-甲基-1,2,4-三唑(2a～2e),4-N-取代苄基氨基-5-甲基-1,2,4-三唑(3a～3e)和2-N-2′,3′,4′,6′-四-O-乙酰基-β-D-吡喃葡萄糖基-4-N-取代苄基氨基-5-甲基-1,2,4-三唑(4a～4e).其结构经IR,1H NMR,13C NMR和元素分析确认.生物活性测试表明,所有化合物均表现出一定的抑菌活性,尤其是化合物4b对大肠杆菌和金黄色葡萄球菌的最小抑菌浓度为8μg/mL,明显优于市售抗菌药物氟康唑,表现出较强的抗细菌活性;同时,与三氯生相比,所有化合物对白色念珠菌的最小抑菌浓度(MIC)均小于或等于32μg/mL,亦表现出较好的抗真菌活性.     

新型S-β-D-葡萄糖苷-1,2,4-三唑的合成及其抗菌活性研究

在氢氧化钾溶液中,取代苯甲酰肼2与CS2生成钾盐3,然后3在水合肼作用下经过环化,得到3-巯基-4-氨基-5-取代芳基-1,2,4三唑(4),在氢氧化钾的丙酮溶液中,与溴代乙酰化α-D-吡喃型葡萄糖反应合成了9个3-S-2′,3′,4′,6′-四-O-乙酰基-β-D-吡喃葡萄糖基-4-氨基-5-取代苯基-1,2,4-三唑(5a~5i).其结构经1H NMR,13C NMR,IR和HRMS确认.对目标化合物进行生物活性测试表明,对大肠杆菌、金黄色葡萄球菌、枯草芽孢杆菌和白色念珠菌均显示了较好的抑菌活性,其中化合物5g对大肠杆菌、金黄色葡萄球菌、枯草芽孢杆菌和白色念珠菌的最小抑菌浓度分别为8,16,64,2μg/m L,效果接近或优于对照药物(三氯生、氟康唑)的抑菌效能,表现出较强的抑菌活性.利用Autodock Vina程序研究了目标化合物(5a~5i)与大肠杆菌Fab I受体蛋白分子的相互作用和结合自由能变化规律.     

新型含1,3,4-噁二唑片段硫色满酮衍生物的设计、合成及其抗真菌活性研究

利用活性亚结构拼接原理,将硫色满酮与1,3,4-噁二唑杂环拼合,设计合成了12个2-(1,3,4-噁二唑)硫色满酮衍生物.目标化合物均经核磁共振氢谱(~1H NMR)和高分辨质谱(HRMS)进行了结构确证.初步的抗真菌活性实验表明,目标化合物对4种动物病原真菌和4种植物病原真菌表现出一定程度的抑制作用.其中,化合物4f对白色念珠菌Canidia albicans的最小抑菌浓度达到了4μg·m L~(-1),4d对花生冠腐病菌Aspergillusnigervan tiegh的最小抑菌浓度达到了8μg·m L~(-1),均高于阳性对照.化合物分子对接研究表明,4f与白色念珠菌CYP51有很强的结合能力,可能为潜在的CYP51抑制剂.     

3-S-(β-D-吡喃葡萄糖基)-1,2,4-三唑的合成及抗菌活性

以自制的5-取代芳基-4-氨基-3-巯基-1,2,4三唑为底物,经糖基修饰后,在甲醇钠/甲醇/二氯甲烷体系中经水解脱除糖环上的乙酰基,得到9个新化合物5-取代苯基-4-氨基-3-S-(β-D-吡喃葡萄糖基)-1,2,4-三唑(6a~6i),其结构经核磁共振波谱(1H NMR,13C NMR),红外光谱(IR)和高分辨质谱(HRMS)确认.生物活性测试结果表明,目标化合物对大肠杆菌、金黄色葡萄球菌、枯草芽孢杆菌和白色念珠菌均显示出良好的抑菌活性.化合物6g对大肠杆菌、金黄色葡萄球菌、枯草芽孢杆菌和白色念珠菌的最小抑菌浓度分别达到2,8,32和8μg/m L,抑菌效果接近或优于对照药物三氯生和氟康唑.利用Autodock程序研究了目标化合物(6a~6i)与大肠杆菌烯脂酰还原酶(FabⅠ)受体蛋白分子的相互作用和结合自由能变化规律.     

含吡唑取代基的1,2,4-三唑[3,4-b]-1,3,4-噻二唑类衍生物的合成及生物活性

以4-氨基-5-巯基-1,2,4-均三唑的衍生物和5-吡唑甲酸及其衍生物为原料,设计合成21个未见报道的新的3-取代-6-吡唑基-1,2,4-三唑[3,4-b]-1,3,4-噻二唑类化合物.通过IR和1H NMR及元素分析对化合物结构进行表征.小麦芽鞘法对目标化合物生长活性测试结果表明,所合成的化合物均表现出不同程度的生长活性;抑菌活性测试结果表明部分化合物表现出较好的抑菌活性.其中化合物3g和3h的活性最好,与氯霉素相似.对大肠杆菌和金黄色葡萄球菌的抗菌药物最低抑菌浓度(MIC值)3g达到6.25和3.13 mg/L,3h达到12.5和6.25 mg/L.     

3-S-(β-D-吡喃葡萄糖基)-1,2,4-三唑的合成及抗菌活性

以自制的5-取代芳基-4-氨基-3-巯基-1,2,4三唑为底物, 经糖基修饰后, 在甲醇钠/甲醇/二氯甲烷体系中经水解脱除糖环上的乙酰基, 得到9个新化合物5-取代苯基-4-氨基-3-S-(β-D-吡喃葡萄糖基)-1,2,4-三唑(6a~6i), 其结构经核磁共振波谱(¹H NMR, ¹³C NMR), 红外光谱(IR)和高分辨质谱(HRMS)确认. 生物活性测试结果表明, 目标化合物对大肠杆菌、 金黄色葡萄球菌、 枯草芽孢杆菌和白色念珠菌均显示出良好的抑菌活性. 化合物6g对大肠杆菌、 金黄色葡萄球菌、 枯草芽孢杆菌和白色念珠菌的最小抑菌浓度分别达到2, 8, 32和8 μg/mL, 抑菌效果接近或优于对照药物三氯生和氟康唑. 利用Autodock程序研究了目标化合物(6a~6i)与大肠杆菌烯脂酰还原酶(FabⅠ)受体蛋白分子的相互作用和结合自由能变化规律.     

2-（1,3,4-噻二唑胺甲基）苯酚的合成及其杀菌活性

以2-氨基-5-烃基-1,3,4-噻二唑和水杨醛为原料,分别用"分步法"和"一锅法"经还原中间产物Schiff碱的CN双键合成了一系列2-((1,3,4-噻二唑基)胺甲基)苯酚类新化合物,"一锅法"的产率较高,为56%～80%。产物的结构用IR、1H NMR、13C NMR和MS进行了表征。初步测试了目标化合物的杀菌活性,证明化合物对赤星病菌具有较好的抑菌活性,当浓度为25 mg/L时,化合物3i的抑制率为76%,化合物3f、3h、3k和3l的为70%。     

新型1,2,3-三唑类化合物的合成及抗菌构效关系

根据活性基团拼接原理, 以4-取代-苯胺为原料, 经重氮化、 关环和缩合反应合成了17个化合物1-(4-取代苯基)-5-取代苯基亚氨基-4-取代-1,2,3-三唑(7a~7c和13a~13d)和1-(4-取代苯基)-5-取代苄基氨基-4-取代-1,2,3-三唑(5a~5c, 10a~10c和14a~14d), 其中化合物5a~5c, 7b, 7c, 10a, 10c, 13b~13d和14b~14c为新化合物, 对所制备化合物的结构进行了表征. 生物活性测试结果表明, 所有化合物均表现出一定的抑菌活性, 对大肠杆菌的抑菌活性均优于氟康唑; 化合物7a和10c对金黄色葡萄球菌的抑制活性明显优于氟康唑; 而化合物13a和13d则对白色念球菌表现出良好的抑制活性, 与三氯生相当.     

新型含巴比妥酸的芳香酰腙类化合物的合成、晶体结构及抑菌活性

在微波辅助下,1,3-二甲基-5-醛基巴比妥酸与芳氧基/芳胺基乙酰肼及含氮杂环乙酰肼缩合制备新型酰腙化合物,并对其抑菌活性进行评价的研究。 新化合物的结构经过元素分析、红外光谱、核磁共振谱、质谱和X射线单晶衍射等技术手段确认。 体外的抑菌活性实验显示,部分目标化合物呈现出优于环丙沙星的抑菌活性。 经过构效关系分析表明,当芳基为含氮杂环时,所形成的化合物抗菌活性与芳基为苯环时相比明显较强,抑菌活性最强的酰腙化合物2t对金黄色葡萄球菌的最小抑菌浓度(MIC)值为0.8 g/L,对大肠杆菌的最小抑菌浓度(MIC)值为1.6 g/L。     

Synthesis and Antibacterial Activity of Oxazolidinone Derivatives Containing Nitro Heteroaromatic Moiety

A series of novel oxazolidinone derivatives containing nitro heteroaromatic moiety was synthesized and characterized by means of ¹H NMR and MS spectra. All target compounds were evaluated for their in vitro antibacterial activities against S.au 29213, methicillin-resistant Staphylococcus aureus(MRSA) and vancomycin-resistant Enterococcus(VRE) by minimum inhibitory concentration(MIC) assay. Most of them exhibited antibacterial activity against S. au 29213, MRSA and VRE. Among them, compounds 10e and 10f displayed better activity than the control.     

Design and Synthesis of Novel 6‐(5‐Methyl‐1H‐1,2,3‐triazol‐4‐yl)‐5‐[(2‐(thiazol‐2‐yl)hydrazono)methyl]imidazo[2,1‐b]thiazoles as Antimicrobial Agents

Novel 6‐(1,2,3‐triazol‐4‐yl)‐5‐[(2‐(thiazol‐2‐yl)hydrazono)methyl]imidazo[2,1‐b ]thiazoles 7 , 9a , 9b , 9c , 9d , and 11 were prepared by reaction of thiosemicarbazone 5a , 5b with either hydrazonoyl chloride 6 , phenacylbromides 8 or 2‐bromo‐1‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)ethanone 10 respectively. The new products were tested for their antimicrobial activities using 96‐well micro‐plate assay, and compound 7 showed excellent antibacterial activities compared with Vancomycine (reference drugs), while compounds 5b and 9c exhibited good results against yeast. The minimum inhibitory concentration (MIC) was determined, and compound 7 showed the lowest MIC against Gram positive bacteria while compound 5b showed the lowest MIC against yeast.     

含苯并咪唑和异噁唑结构席夫碱的合成及其抑菌活性

根据活性亚结构拼接原理,以取代苯甲醛、盐酸羟胺、N-氯代丁二酰亚胺和2-苯并咪唑基乙腈等为原料,经肟化、氯代、环化及缩合反应,合成了一系列新型的含苯并咪唑和异噁唑结构的席夫碱化合物(5a~5h),收率60%~75%,其结构经~1H NMR,~(13)C NMR,IR和HR-MS表征。采用菌丝生长速率法测试了化合物对番茄灰霉菌和生菜菌核菌的抑菌活性。结果表明:在用药量为100μg·m ~(-1)时,苯环上含有氟原子或甲氧基的席夫碱(5c,5d和5e)对生菜菌核菌显示出较好的活性,抑制率为71.3%~76.1%。     

Synthesis,spectroscopic, DNA cleavage and antibacterial activity of binuclear schiff base complexes

The binuclear Schiff base complexes are formed newly using different transition metals at their stable oxidation state as Cu(II), Ni(II), and VO(II). 3,3′,4,4′-tetraminobiphenyl and 2-aminobenzaldehyde were condensed to form a new Schiff base ligand having an two N₄ group responsible for better chelating to the metal centers. The ligand and their complexes have been established by analytical, spectral and electrochemical data. The interaction studies of the complexes with CT-DNA were carried out using cyclic voltammetry, viscosity measurements and fluorescence spectroscopy. The free ligand and their metal complexes were screened for their antimicrobial activities against the following species: Klebsiella pneumoniae, Escherichia coli and Staphylococcus aureus. A comparative study of minimum inhibitory concentration (MIC) values of the Schiff base and its complexes indicate that the metal complexes exhibit higher antibacterial activity than the free ligand.     

Novel Pyrazoline‐based Organometallic Compounds Containing Ferrocenyl and Quinoline units: Synthesis,Characterization and Microbial susceptibilities

Some novel pyrazoline‐based organometallic compounds were synthesized as new leads in antimicrobial chemotherapy. The structures of compounds were elucidated by different spectroscopic techniques and elemental analyses. All compounds were investigated for in vitro antimicrobial studies against fifteen ATTC bacterial and fungal strains. The microbial susceptibility of these compounds revealed that all the tested compounds gave good minimum inhibitory concentration (MIC) values against the tested organisms that are either similar or even better than the reference drugs amoxicillin and fluconazole, which gave MIC values 8‐64 μg/ml against bacterial and 64 μg/ml against fungal strains, respectively. Among all compounds, compound ( 4d ) 1‐(5‐(4‐chlorophenyl)‐3‐ferrocenyl‐4,5‐dihydropyrazol‐1‐yl)‐2‐quinolin‐8‐yloxy) ethanone, emerged out the most promising antimicrobial organometallic derivative with MIC values against all the strains ranging from 8‐32 μg/ml. Other compounds gave a range of MIC values between 16‐64 μg/ml against S. bovis, 16‐32 μg/ml against E. coli, and C. tropicalis except compound ( 4d) which gave MIC 8 μg/ml against S. bovis and E. coli, whereas 32 μg/ml against C. tropicalis. Collectively, these compounds gave a lower MIC value between 32‐64 μg/ml against both of the biofilm forming strains namely, P. aeruginosa and S. mutans. The results of microbial susceptibility concluded that these novel organometallic compounds are new leads in antimicrobial chemotherapy and can be very useful for further optimization work on microbial chemotherapy.     

Synthesis and Antimicrobial and Antioxidant Activities of Sulfonamide Derivatives Containing Tetrazole and Oxadiazole Rings

In the present work, we synthesized new sulfonamide derivatives with 1,3,4‐oxadiazole moiety and tetrazole ring. The synthesized derivatives of sulfonamides were characterized through Fourier transform infrared, ¹³C‐APT‐NMR, ¹H‐NMR, and high‐resolution liquid chromatography–mass spectrometry. The biological activities of resulting compound were also investigated and observed that the compounds reveal strong antimicrobial activity over some important bacterial strains including Bacillus subtilis ATCC 6633, Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 13883, and Staphylococcus aureus ATCC 29213. The in vitro antifungal properties of synthesized compounds were also a target using Candida albicans NRRL Y‐477 and Saccharomyces cerevisiae fungal strains. We have provided a useful guideline for future studies about the effect of the chemical structures of sulfonamide compounds on the biological activities. Among the target compounds, 7b , 7c , 7d , and 7e demonstrated surprisingly high antimicrobial activities than did others.     

香豆素席夫碱衍生物的合成及抗肿瘤活性研究

设计合成了18个未见文献报道的含席夫碱结构的香豆素衍生物,其结构经1H NMR,13C NMR,ESI-MS和元素分析确证.体外对人口腔鳞癌细胞KB及多药耐药株KBv200的初步毒性试验表明,化合物4a,4b,5b,3d和4d具有中等的抗肿瘤活性,并对其构效关系进行了讨论.